Microbiological profile of patients with generalized gingivitis undergoing periodontal therapy and administration of Bifidobacterium animalis subsp. lactis HN019: A randomized clinical trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0310529 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Flavia Furlaneto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral & Maxillofacial Surgery and Periodontology, Ribeirao Preto School of Dentistry, University of Sao Paulo-USP, Ribeirao Preto, SP, B…. Hauptthemen laut MEDLINE: Gingivitis, Probiotics, Bifidobacterium animalis. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danisco Sweeteners Oy.
Abstract (Originalsprache)
Objective
To evaluate the adjunctive use of the probiotic Bifidobacterium animalis subsp. lactis HN019 ( B . lactis HN019) to conventional therapy on clinical and microbiological parameters in patients with generalized gingivitis.
Methods
Sixty systemically healthy individuals with untreated generalized gingivitis were submitted to periodontal therapy and allocated to receive Placebo ( n = 30) or Probiotic ( n = 30) lozenges, twice a day for 8 weeks. Bleeding on Marginal Probing (BOMP) was evaluated at baseline, after 2 and 8 weeks. Supra and subgingival biofilm were obtained at baseline and 8 weeks post-therapy for analyses by 16S rRNA gene sequencing. Differences between therapeutic groups were analyzed by non-parametric tests ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral & Maxillofacial Surgery and Periodontology, Ribeirao Preto School of Dentistry, University of Sao Paulo-USP, Ribeirao Preto, SP, Brazil.
- Division of Post-graduate Periodontics, School of Dentistry, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Oral Microbiology Laboratory, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Department of Clinical Analyses, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo-USP, Ribeirao Preto, SP, Brazil.
ORCID-Profile: Flavia Furlaneto, Débora de Souza Ferreira Sávio, Adriana Miranda de Oliveira, Pedro Henrique Felix Silva
Förderung
- Danisco Sweeteners Oy
Zitieren
APA
Furlaneto, F., Levi, Y. L. A. S., Sávio, D. S. F., da Silveira, I. C. F., de Oliveira, A. M., Lourenço, T. G. B., Ribeiro, M. C., Silva, P. H. F., Salvador, S. L. S., Colombo, A. P. V., & Messora, M. R. (2024). Microbiological profile of patients with generalized gingivitis undergoing periodontal therapy and administration of Bifidobacterium animalis subsp. lactis HN019: A randomized clinical trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0310529
Vancouver
Furlaneto F, Levi YLAS, Sávio DSF, da Silveira ICF, de Oliveira AM, Lourenço TGB, et al. Microbiological profile of patients with generalized gingivitis undergoing periodontal therapy and administration of Bifidobacterium animalis subsp. lactis HN019: A randomized clinical trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0310529
BibTeX
@article{Furlaneto2024,
author = {Furlaneto, Flavia and Levi, Yara Loyanne de Almeida Silva and Sávio, Débora de Souza Ferreira and da Silveira, Izadora Cianfa Firmino and de Oliveira, Adriana Miranda and Lourenço, Talita Gomes Baêta and Ribeiro, Marcella Costa and Silva, Pedro Henrique Felix and Salvador, Sergio Luiz de Souza and Colombo, Ana Paula Vieira and Messora, Michel Reis},
title = {Microbiological profile of patients with generalized gingivitis undergoing periodontal therapy and administration of Bifidobacterium animalis subsp. lactis HN019: A randomized clinical trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0310529}
}
EUVIMED